•] Shares Codiak BioSciences, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • February 9th, 2021 • Codiak BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 9th, 2021 Company Industry Jurisdiction
Re: Employment AgreementEmployment Agreement • February 9th, 2021 • Codiak BioSciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionThis letter agreement (the “Agreement”) is made as of September 23, 2020 between Codiak BioSciences, Inc., a Delaware corporation (“Codiak” or the “Company”), and Yalonda Howze (the “Executive”) (together, the “parties”) and is effective as of, and conditioned on, the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the date of such closing, the “Effective Date”).